Optometrist · Bronx, NY
NPI
1245230861
Since 2005
Specialty
Optometrist
Code 152W00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
103 W Kingsbridge Rd
Bronx, NY, 10468
Phone (718) 432-5555
Medicare paid, 2024
$27K
407 services
Medicare patients, 2024
102
Average age 70
Drug cost, 2024
$1.5M
2,538 prescriptions
Company payments, 2025
$1,682
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter S Bae was code 92014 (ophthalmological e&m), 126 times for 87 patients. In total Peter S Bae billed 407 services in 18 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 126 | 87 | $100.83 | $13K |
| 92250 Angiography | Office | 102 | 89 | $29.70 | $3,030 |
| 68761 Eye | Office | 42 | 19 | $98.44 | $4,134 |
| 92020 Ophthalmological E&M | Office | 28 | 28 | $22.52 | $631 |
| 92083 Vision, Hearing, and Speech Services | Office | 27 | 26 | $46.35 | $1,251 |
| 92133 Computerized Ophthalmic Imaging | Office | 23 | 20 | $27.80 | $639 |
| 92004 Ophthalmological E&M | Office | 15 | 15 | $114.83 | $1,722 |
| 92273 Test - Miscellaneous | Office | 14 | 13 | $115.82 | $1,622 |
By year: 2022 $37K for 538 services; 2023 $31K for 476 services; 2024 $27K for 407 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter S Bae prescribed most often to Medicare patients was Xiidra (Lifitegrast), with 586 prescriptions and refills. In total Peter S Bae wrote 2,538 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xiidra Lifitegrast | 586 | 790 | 171 | $519K |
| Miebo Perfluorohexyloctane/Pf | 359 | 376 | 102 | $275K |
| Restasis Cyclosporine | 328 | 543 | 101 | $324K |
| Eysuvis Loteprednol Etabonate | 302 | 311 | 131 | $146K |
| Azelastine Hcl Generic | 207 | 243 | 60 | $2,456 |
| Latanoprost Generic | 200 | 351 | 66 | $1,787 |
| Lumigan Bimatoprost | 185 | 327 | 57 | $88K |
| Cequa Cyclosporine | 70 | 102 | 23 | $55K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 34 | 42 | Under 11 | $14K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 34 | 36 | 25 | $2,598 |
| Restasis Multidose Cyclosporine | 33 | 83 | Under 11 | $48K |
| Cyclosporine Generic | 30 | 60 | 19 | $13K |
| Brimonidine Tartrate Generic | 27 | 44 | Under 11 | $2,481 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 24 | 34 | Under 11 | $341 |
| Combigan Brimonidine Tartrate/Timolol | 23 | 39 | Under 11 | $8,545 |
Brand drugs: 2,065 claims; generic drugs: 473 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter S Bae $1,682 ($1,682 in general payments such as food, travel and fees) from 9 companies. The largest payer was Alcon Vision LLC with $817.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.